Department of Cardiovascular Disease, Vidant Medical Center/East Carolina University, Greenville, NC, USA.
Department of Cardiology, Arrhythmia unit, Sorbonne Université, INSERM, AP-HP, Pitié-Salpêtrière Hospital, 75013 Paris, France.
Therapie. 2022 May-Jun;77(3):265-271. doi: 10.1016/j.therap.2021.10.008. Epub 2021 Oct 24.
The prevalence and incidence of cardiac pro-arrhythmic disorders are often influenced by sex due to specific effects on the QT interval. Androgens shorten QT, which may be protective against acquired long QT syndromes and their related arrhythmias in men such as torsade de pointes (TdP). On the other hand, androgens can potentiate Brugada and early repolarization syndromes, which are most prevalent in men. In this case series, we highlight four male patients with aborted SCD in the setting of abnormal testosterone status; two patients with TdP in a setting of testosterone deprivation (of which one drug-induced) and 2 patients with ventricular fibrillation associated with exogenous androgenic booster (Tribulus terrestris) intake. From this case series, we review the current available literature of the effects of androgen as a double-edged sword on the QTc interval and emphasize the importance of QTc monitoring in this subset of patients.
由于对 QT 间期的特定影响,心脏致心律失常障碍的患病率和发病率通常受性别影响。雄激素缩短 QT 间期,这可能对男性获得性长 QT 综合征及其相关心律失常(如尖端扭转型室性心动过速[Tdp])具有保护作用。另一方面,雄激素可增强 Brugada 和早期复极综合征,这些在男性中最为常见。在本病例系列中,我们强调了 4 名因睾丸激素状态异常而发生心源性猝死中止的男性患者;2 名 Tdp 患者的睾丸激素剥夺(其中 1 例为药物诱导)和 2 名与外源性雄激素增强剂(蒺藜)摄入相关的室性颤动患者。通过本病例系列,我们回顾了目前关于雄激素作为双刃剑对 QTc 间期影响的可用文献,并强调了在这部分患者中进行 QTc 监测的重要性。